Steven R Whittaker

7PUBLICATIONS
21CO-AUTHORS
Solid tumoursPredictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Nov 26, 2022
Tissue-Specific Human Extracellular Matrix Scaffolds Promote Pancreatic Tumour Progression and Chemotherapy Resistance.

Walid Al-Akkad, Pilar Acedo, Maria-Giovanna Vilia

|Aug 31, 2021
A phospho-proteomic study of cetuximab resistance in KRAS/NRAS/BRAFV600 wild-type colorectal cancer.

Alexandros Georgiou, Adam Stewart, Georgios Vlachogiannis

|May 07, 2020
A Genome-scale CRISPR Screen Identifies the ERBB and mTOR Signaling Networks as Key Determinants of Response to PI3K Inhibition in Pancreatic Cancer.

Charlotte K Milton, Annette J Self, Paul A Clarke

|Feb 27, 2020
Inactivation of NF1 Promotes Resistance to EGFR Inhibition in KRAS/NRAS/BRAFV600 -Wild-Type Colorectal Cancer.

Alexandros Georgiou, Adam Stewart, David Cunningham

|Dec 11, 2019
Increased inflammatory lipid metabolism and anaplerotic mitochondrial activation follow acquired resistance to vemurafenib in BRAF-mutant melanoma cells.

Teresa Delgado-Goñi, Teresa Casals Galobart, Slawomir Wantuch

|Jun 01, 2019
Correction: Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancer.

Steve Wagner, Georgios Vlachogiannis, Alexis De Haven Brandon

Pageof 2

Frequent Collaborators

3 joint publications

Udai Banerji

2 joint publications

Kate Eason

2 joint publications

David Cunningham

1 joint publications

Teresa Delgado-Goñi